IDXX - IDEXX Laboratories, Inc.
| Previous Close | 273.93 |
| Open | 274.81 |
| Bid | 269.01 x 1000 |
| Ask | 279.46 x 800 |
| Day's Range | 272.82 - 275.84 |
| 52 Week Range | 176.11 - 278.61 |
| Volume | 229,828 |
| Avg. Volume | 433,775 |
| Market Cap | 23.653B |
| Beta (3Y Monthly) | 1.26 |
| PE Ratio (TTM) | 62.22 |
| EPS (TTM) | 4.42 |
| Earnings Date | Jul 30, 2019 - Aug 5, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 267.20 |
- Motley Fool•18 hours ago
2 Stocks to Play the Pet Care Trend
With consumers spending as much as $72 billion on their pets in 2018, here are 2 companies that could benefit most from our love of animals.
- Zacks•4 days ago
IDEXX (IDXX) Gains Traction From Solid CAG, Global Strength
IDEXX (IDXX) consistently benefits from strong organic growth, driven by robust sales at the CAG business, fueled by a firm global Catalyst adoption.
- Zacks•4 days ago
Near-Term Outlook for Medical Instruments Industry Bleak
Near-Term Outlook for Medical Instruments Industry Bleak
- Zacks•11 days ago
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
Sector ETF report for XHE
- Simply Wall St.•15 days ago
Does IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) CEO Pay Matter?
Jon Ayers became the CEO of IDEXX Laboratories, Inc. (NASDAQ:IDXX) in 2002. First, this article will compare CEO...
- Insider Monkey•15 days ago
Were Hedge Funds Right About Flocking Into IDEXX Laboratories, Inc. (IDXX) ?
The government requires hedge funds and wealthy investors that crossed the $100 million equity holdings threshold are required to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings level the playing field for ordinary investors. The latest round of 13F filings disclosed the […]
- Markit•15 days ago
See what the IHS Markit Score report has to say about Idexx Laboratories Inc.
Idexx Laboratories Inc NASDAQ/NGS:IDXXView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for IDXX with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting IDXX. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding IDXX totaled $13.75 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Zacks•25 days ago
Why Is Idexx (IDXX) Up 3% Since Last Earnings Report?
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks•27 days ago
Here's Why You Should Invest in IDEXX Laboratories (IDXX) Now
IDEXX (IDXX) registers strong revenue growth on the back of CAG Diagnostics.
- TheStreet.com•last month
Idexx Labs Could Be Forming a Double Top or Just Pausing in an Uptrend
For his Executive Decision segment of "Mad Money" Wednesday our own Jim Cramer sat down with Jonathan Ayers, chairman, president and CEO of Idexx Laboratories Inc. IDXX, an animal health company. For those pets who do see their vet, however, diagnostics from Idexx are becoming an integral part of their care. Ayers said Idexx continues to innovate, which helps it see strong organic growth and increased operating margins.
- CNBC•last month
Idexx Labs is counting on millennials to boost the pet-care industry
"[Millennials] are more likely to go to the vet more frequently and more willing to listen to an advanced standard of care," CEO Jonathan Ayers says. About 42% of millennials think their pets have special health needs — more than double the percentage of the baby boomer generation, he said. Idexx Laboratories IDXX has room to grow in providing preventative care for pets, CEO Jonathan Ayers told CNBC Wednesday.
- GuruFocus.com•last month
Baron Capital Commentary: 3 Opportunities in the Animal Health Space
By Portfolio Manager Neal Rosenberg: How the 'humanization' of pets has created a booming industry
- PR Newswire•last month
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
WESTBROOK, Maine , May 20, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate ...
- Simply Wall St.•last month
Should You Like IDEXX Laboratories, Inc.’s (NASDAQ:IDXX) High Return On Capital Employed?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...
- GuruFocus.com•2 months ago
Idexx Laboratories Inc (IDXX) Chairman, President & CEO Jonathan W Ayers Sold $7 million of ...
Chairman, President & CEO of Idexx Laboratories Inc (NASDAQ:IDXX) Jonathan W Ayers sold 28,000 shares of IDXX on 05/03/2019 at an average price of $249.02 a share.
- Zacks•2 months ago
Moving Average Crossover Alert: IDEXX Laboratories
IDEXX Laboratories is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of IDXX earnings conference call or presentation 1-May-19 12:30pm GMT
Q1 2019 IDEXX Laboratories Inc Earnings Call
- Benzinga•2 months ago
Jim Cramer Shares His Thoughts On Cirrus Logic, Chart Industries And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he is not a trucker fan and he wants to stay away from Knight-Swift Transportation Holdings Inc (NYSE: KNX ). Cramer prefers Barrick Gold ...
Motley Fool•2 months agoIDEXX Laboratories Inc (IDXX) Q1 2019 Earnings Call Transcript
IDXX earnings call for the period ending March 31, 2019.
- Motley Fool•2 months ago
Rising Margins Allow IDEXX Laboratories to Boost Guidance
Expense control is helping the animal diagnostic company drive double-digit profit growth.
- Zacks•2 months ago
Idexx Laboratories (IDXX) Beats Q1 Earnings and Revenue Estimates
Idexx (IDXX) delivered earnings and revenue surprises of 12.50% and 0.83%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
- Zacks•2 months ago
IDEXX (IDXX) Q1 Earnings Top Estimates, EPS Guidance Up
Strong sales at the CAG business favor IDEXX's (IDXX) top line in Q1.
- Associated Press•2 months ago
Idexx: 1Q Earnings Snapshot
On a per-share basis, the Westbrook, Maine-based company said it had net income of $1.17. The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ...
